Skip to Main Content

Paper Details

SRC Family Kinase Inhibition Targets YES1 and YAP1 as Primary Drivers of Lung Cancer and as Mediators of Acquired Resistance to ALK and Epidermal Growth Factor Receptor Inhibitors.
JCO Precis Oncol
7
2022
Author NameAffiliation
Gregory J RielyMemorial Sloan Kettering Cancer Center
Marc LadanyiMemorial Sloan Kettering Cancer Center
  • 1 - 2

Datasets

Release 1.2